The AHA, Association of American Medical Colleges, America’s Essential Hospitals, and Federation of American Hospitals today urged the Centers for Medicare & Medicaid Services to share additional information with hospitals and the public about how accurately its overall hospital quality star ratings portray hospital performance and work with hospitals to validate the methodology, or continue to withhold publication of the ratings. “Since the sole purpose for creating the star ratings was to provide accurate information to the public to guide their decision-making about where to get their care, hospitals and patients alike must have meaningful information on whether the assessment is fair and accurate,” the organizations wrote. “…In fact, the minimal data available to us do not offer substantive proof that the methodology works as it was intended, and raise many more questions and concerns about the methodology than they answer.” Further, an analysis by an independent expert “gave us strong reason to believe that the assumptions on which the current model is based are flawed in a number of ways,” the organizations said. For more on the issue, see today’s AHA STAT blog post by AHA President and CEO Rick Pollack.

Related News Articles

Headline
Hospitals, health systems and other health care organizations can sign up this week to host an intern for this year's Institute for Diversity and Health Equity…
Headline
The Centers for Disease Control and the National Tuberculosis Controllers Association this week released updated recommendations for TB screening and testing…
Headline
The House Ways and Means Committee today held a hearing examining the impact of racial disparities and social determinants of health on maternal mortality.
Headline
The Centers for Medicare…
Headline
The Food and Drug Administration last week alerted health care providers and patients that batteries in certain Medtronic implantable pacemakers and cardiac…
Headline
The Food and Drug Administration Friday issued final guidance clarifying how sponsors may show that a proposed biosimilar product is interchangeable with a…